Call centre software producer Replicant closed a $78m series B round backed by Salesforce Ventures while Ashvattha Therapeutics raised $69m from investors including strategic partner Huadong Medicine.

Corporate-backed medical imaging technology producer Lunit is preparing to float in South Korea while cancer drug developer Pheast secured $76m from investors including Alexandria Venture Investments.

Yangtze River Pharmaceutical Group led Binhui Biopharm's $47m series B-plus round while Sigfox has been snapped up by UnaBiz for under $30m after raising over $300m.

Web3 security software producer Certik received $60m from investors including SoftBank Vision Fund 2 while corporate-backed automation technology provider Vicarious is being bought after raising over $250m.

Bristol Myers Squibb was among the investors in a series B round announced alongside a collaboration with the small molecule drug developer.

Accenture, Workday and Bank of America helped VR training technology developer Strivr expand its latest round to $65m while Consensys backed a $50m round for blockchain analytics provider Flipside Crypto.

Citi Ventures, Salesforce Ventures and Telstra Ventures all invested in blockchain infrastructure provider Blockdaemon's series D round while GV backed cybersecurity software provider Obsidian's $90m series C.

BMW and Ralph Lauren contributed to an $85m round for sustainable materials provider Natural Fiber Welding while Credit Saison invested $80m in virtual credit card service Julo.

Decentralised finance technology developer BloXroute raised $70m in a round led by SoftBank Vision Fund 2 while Ackermans & van Haaren helped digital health technology developer Medikabazaar score a $700m valuation.

Recombinant protein technology provider Healthgen netted over $87m while shared living space provider Hmlet is buying corporate-backed peer Habyt and Uniswap Labs is launching an investment vehicle.